Education
About Us
Working with TipRanks
Follow Us
Veda Pharmyne Profile - AI Firm Analyst
4 Followers
Veda Pharmyne AI Firm
Wall Street Analyst
Success Rate
25 out of 41 ratings made a profit
Average Return
+0.30%
Average return per rating
Time Frame
Compare to
Copying Veda Pharmyne's trades since 2025 and holding each position for 1 Year would result in 60.98% of your transactions generating a profit, with an average return of 0.3% per rating.
Stock Rating Distribution
69.90% Buy
27.18% Hold
2.91% Sell
Distribution of Veda Pharmyne's ratings
Additional Information
Main Sector:General
Geo Coverage:
US Market
UK Market
France Market
Hong Kong Market
Australian Market
Germany Market
Spanish Market
US MarketUK MarketFrance MarketHong Kong MarketAustralian MarketGermany MarketSpanish MarketBest Rating
The most profitable rating made by Veda Pharmyne
Veda Pharmyne's Stock Coverage
Gilead Sciences
May 22, 2025
Buy
Reiterated
$119.00
(8.54%Upside)
1Ratings
+8.00%
Novartis AG
May 22, 2025
Buy
Reiterated
CHF108.00
(12.23%Upside)
1Ratings
+6.60%
Virbac SA
May 27, 2025
Buy
Reiterated
€359.00
(4.06%Upside)
3Ratings
+10.40%
Organon
May 29, 2025
Hold
Reiterated
$9.50
(-4.43%Downside)
1Ratings
―
0.00%
Amgen
May 31, 2025
Buy
Reiterated
$324.00
(9.73%Upside)
1Ratings
+4.20%
InDex Pharmaceuticals Holding AB
May 31, 2025
Hold
Reiterated
kr45.00
(-4.05%Downside)
2Ratings
―
0.00%
Bayer
Jun 05, 2025
Hold
Reiterated
€26.00
(-4.90%Downside)
1Ratings
―
0.00%
Grifols
Jun 05, 2025
Buy
Reiterated
€11.50
(-1.03%Downside)
1Ratings
+12.80%
Grifols SA
Jun 06, 2025
Hold
Reiterated
$9.50
(-2.46%Downside)
1Ratings
―
0.00%
COSMO Pharmaceuticals N.V.
Jun 06, 2025
Buy
Reiterated
CHF66.00
(6.28%Upside)
2Ratings
+9.50%
List of latest recommendations made by Veda Pharmyne. Click to expand and see Veda Pharmyne's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Veda Pharmyne activity FAQ
What is the performance of Veda Pharmyne's recommendations?
The percentage of profitable recommendations made by Veda Pharmyne is 61%, and the average return per transaction is 0.30%.
What was Veda Pharmyne's most profitable rating?
Veda Pharmyne’s most profitable ratings was a buy on CH:COPN stock on May 24, 2025 - Today. The return on the trade was +15.40%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here